What is the diffrence in japan mkt requirement in analytical method validation over US?
- 1 Answers
- 813 Views
- I also Faced
- E-Mail Answers
Answer Posted / Ganesh Prasad
The differences between Japan and US market requirements for analytical method validation primarily lie in regulatory guidelines and standards. The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has its own guidelines such as 'Guideline on Pre-clinical Safety Studies' and 'Guideline on Good Clinical Practice'. On the other hand, the US Food and Drug Administration (FDA) follows Title 21 of the Code of Federal Regulations (CFR) Parts 58 and 600 for method validation. Additionally, there might be variations in acceptance criteria, like precision, accuracy, specificity, and robustness based on regional guidance documents.
| Is This Answer Correct ? | 0 Yes | 0 No |
Post New Answer View All Answers
What is the principle of HPLC, GC, LCMS, GCMS,LC QQQ, GC QQQ, LC Q TOF and GC Q TOF. What are the applications and Specificity?
what is the disso medium for tropsiun chloride
what is the extinction coefficient for Indomethacin or at 319nm wave length.
i want model written test paper for the post of analyst in IOCL(indian oil corporation ltd) any one pls help me
what is the principle of UV Vis spectroscopy, AAS, ICP OES,ICPAES, ICP-MS and FTIR
